Xiao-Ping Luo

InstitutionHuaZhong University of Science and Technology
AddressWuhan
Hubei
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 3 Covid-19 publications, with a maximum of 1 publications in March 2020 and August 2020 and October 2020
    All Publications
    Bar chart showing 197 publications over 19 distinct years, with a maximum of 21 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Dong QQ, Qiu LR, Cheng LM, Shu SN, Chen Y, Zhao Y, Hao Y, Shi H, Luo XP. Kindergartens Reopening in the Period of Regular Epidemic Prevention and Control, Benefitial or Harmful? Curr Med Sci. 2020 Oct; 40(5):817-821. PMID: 33123896.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    2. Wang SM, Tao F, Hou Y, Zhang A, Xiong H, Sun JJ, Luo XP, Hao Y, Li JX, Hu Q, Liu AG. Screening of SARS-CoV-2 in 299 Hospitalized Children with Hemato-oncological Diseases: A Multicenter Survey in Hubei, China. Curr Med Sci. 2020 Aug; 40(4):642-645. PMID: 32767262.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    3. Wang SS, Zhou X, Lin XG, Liu YY, Wu JL, Sharifu LM, Hu XL, Rong ZH, Liu W, Luo XP, Chen Z, Zeng WJ, Chen SH, Ma D, Chen L, Feng L. Experience of Clinical Management for Pregnant Women and Newborns with Novel Coronavirus Pneumonia in Tongji Hospital, China. Curr Med Sci. 2020 Apr; 40(2):285-289. PMID: 32219626.
      Citations: 19     Fields:    Translation:HumansCellsPHPublic Health
    4. Wu D, Yan WM, Wang HW, Huang D, Luo XP, Ning Q. ?d T Cells Contribute to the Outcome of Murine Fulminant Viral Hepatitis via Effector Cytokines TNF-a and IFN-?. Curr Med Sci. 2018 Aug; 38(4):648-655. PMID: 30128874.
      Citations: 5     Fields:    Translation:AnimalsCells
    5. Yu H, Liu Y, Huang J, Wang H, Yan W, Xi D, Shen G, Luo X, Ning Q. IL-33 protects murine viral fulminant hepatitis by targeting coagulation hallmark protein FGL2/fibroleukin expression. Mol Immunol. 2017 07; 87:171-179. PMID: 28494352.
      Citations: 3     Fields:    Translation:AnimalsCells
    6. Wu D, Wang H, Yan W, Chen T, Wang M, Han M, Wu Z, Wang X, Ai G, Xi D, Shen G, Luo X, Ning Q. A disparate subset of double-negative T cells contributes to the outcome of murine fulminant viral hepatitis via effector molecule fibrinogen-like protein 2. Immunol Res. 2016 Apr; 64(2):518-30. PMID: 26482053.
      Citations: 4     Fields:    Translation:AnimalsCells
    7. Li Y, Han MF, Li WN, Shi AC, Zhang YY, Wang HY, Wang FX, Li L, Wu T, Ding L, Chen T, Yan WM, Luo XP, Ning Q. SOCS3 expression correlates with severity of inflammation in mouse hepatitis virus strain 3-induced acute liver failure and HBV-ACLF. J Huazhong Univ Sci Technolog Med Sci. 2014 Jun; 34(3):348-353. PMID: 24939297.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    8. Zhou YY, Zou Y, Chen T, Wang HW, Han MF, Pi B, Yan WM, Xi D, Huang JQ, Luo XP, Ning Q. [KCTD9, a novel potassium channel related gene, was highly expressed in hepatic NK cells and T cells of fulminant hepatitis mice induced by MHV-3]. Zhonghua Gan Zang Bing Za Zhi. 2011 Nov; 19(11):833-7. PMID: 22433305.
      Citations: 2     Fields:    Translation:AnimalsCells
    9. Wu ZG, Yan WM, Guo W, Chen T, Zou Y, Wang HW, Wang XJ, Yang XJ, Lu YL, Luo XP, Ning Q. Telbivudine preserves T-helper 1 cytokine production and downregulates programmed death ligand 1 in a mouse model of viral hepatitis. J Viral Hepat. 2010 Mar; 17 Suppl 1:24-33. PMID: 20586931.
      Citations: 6     Fields:    Translation:AnimalsCells
    10. Gao S, Wang M, Guo JW, Xi D, Luo XP, Ning Q. Construction of mTNFR1shRNA plasmid and its biological effects on MHV-3 induced fulminant hepatitis in BALB/cJ mice. Virol Sin. 2010 Feb; 25(1):52-8. PMID: 20960284.
      Citations:    Fields:    Translation:AnimalsCells
    11. Wang XJ, Yan WM, Zhang JG, Wang HW, Zou Y, Luo XP, Ning Q. [Role of CD4-CD8- T cells in the murine hepatitis virus type 3 induced chronic viral hepatitis]. Zhonghua Gan Zang Bing Za Zhi. 2009 Mar; 17(3):180-3. PMID: 19335979.
      Citations:    Fields:    Translation:AnimalsCells
    12. Zou Y, Chen T, Wang HW, Yan WM, Luo XP, Ning Q. [The functions of liver natural killer cells in murine fulminant hepatitis induced by murine hepatitis virus strain 3]. Zhonghua Gan Zang Bing Za Zhi. 2008 Sep; 16(9):660-4. PMID: 18822205.
      Citations:    Fields:    Translation:AnimalsCells
    13. Han M, Yan W, Huang Y, Yao H, Wang Z, Xi D, Li W, Zhou Y, Hou J, Luo X, Ning Q. The nucleocapsid protein of SARS-CoV induces transcription of hfgl2 prothrombinase gene dependent on C/EBP alpha. J Biochem. 2008 Jul; 144(1):51-62. PMID: 18390877.
      Citations: 13     Fields:    Translation:HumansAnimalsCells
    14. Zhu C, Sun Y, Luo X, Yan W, Xi D, Ning Q. Novel mfgl2 antisense plasmid inhibits murine fgl2 expression and ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice. Hum Gene Ther. 2006 Jun; 17(6):589-600. PMID: 16776568.
      Citations: 23     Fields:    Translation:AnimalsCells
    15. Zhu CL, Yan WM, Zhu F, Zhu YF, Xi D, Tian DY, Levy G, Luo XP, Ning Q. Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B. World J Gastroenterol. 2005 Nov 28; 11(44):6936-40. PMID: 16437596.
      Citations: 19     Fields:    Translation:HumansAnimalsCells
    16. Ning Q, Luo XP, Wang ZM, Han MF, Yan WM, Liu MF, Levy G. [The study of cis-element HNF4 in the regulation of mfg12 prothrombinase/fibroleukin gene expression in response to nucleocapsid protein of MHV-3]. Zhonghua Yi Xue Za Zhi. 2003 Apr 25; 83(8):678-83. PMID: 12887828.
      Citations: 2     Fields:    Translation:AnimalsCells
    17. Ning Q, Berger L, Luo X, Yan W, Gong F, Dennis J, Levy G. STAT1 and STAT3 alpha/beta splice form activation predicts host responses in mouse hepatitis virus type 3 infection. J Med Virol. 2003 Mar; 69(3):306-12. PMID: 12526039.
      Citations: 13     Fields:    Translation:AnimalsCells
    18. Ning Q, Yang D, Luo X, Hao L, Gary L. [Fulminant viral hepatitis: mice model and its clinical implications]. Zhonghua Gan Zang Bing Za Zhi. 2002 Jun; 10(3):224-6. PMID: 12113688.
      Citations: 2     Fields:    Translation:HumansAnimalsCells